Last reviewed · How we verify

NCT05408455

Expiratory Muscle Training in Bronchiectasis

Completed NA Last updated 12 March 2024
What this trial tests

NA trial testing EMST150 (Expiratory muscle training) in Bronchiectasis in 29 participants. Completed in 23 January 2023.

Timeline
1 February 2021
Primary endpoint
24 September 2022
23 January 2023

Quick facts

Lead sponsorPamukkale University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment29
Start date1 February 2021
Primary completion24 September 2022
Estimated completion23 January 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Pamukkale University

Who can join

Adults 18 to 70, any sex, with Bronchiectasis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Reduced exercise tolerance is commonly reported in patients with bronchiectasis. The purpose of this study is to evaluate the effects of expiratory muscle training (EMT) and sham EMT (control) on exercise capacity, respiratory function and respiratory muscle strength, cough strength and health related quality of life in patients with bronchiectasis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Bronchiectasis

Currently open trials in the same condition.

Other Pamukkale University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05408455.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing